Short Bowel Syndrome: Clinical Trials

13 trials for Short Bowel Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 terminated, 2 withdrawn, 1 recruiting. 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 413Completed 7, Terminated 3, Withdrawn 2, Recruiting 1

Follow Short Bowel Syndrome: new trials by email Literature Review of Short Bowel Syndrome trials Research Report on Short Bowel Syndrome

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome
rhGH injection - Short Bowel Syndrome (SBS) in Adults
Phase 4RecruitingChangchun GeneScience Pharmaceutical Co., Ltd.1002024-07-312026-07-08
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)
Clinolipid, Intralipid - Essential Fatty Acid Deficiency (EFAD)
Phase 4CompletedBaxter Healthcare Corporation1012021-01-222023-12-27
Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition
Apixaban single dose, Apixaban steady-state - Short Bowel Syndrome, Anticoagulation
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven702020-12-202026-10-15
Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients
Teduglutide - Short Bowel Syndrome
Phase 4CompletedAssistance Publique - Hôpitaux de Paris252018-07-022025-09-11
SMOFLipid in Patients Who Are Intralipid Intolerant
SMOFLipid, Standard therapy - Home Parenteral Nutrition, Short Bowel Syndrome
Phase 4WithdrawnMayo Clinic2017-02-012018-03-22
The Use of DPP-4 Inhibitors in Short Bowel Syndrome
Dipeptidyl peptidase-4 inhibitor - Short Bowel Syndrome
Phase 4TerminatedStanley Dudrick's Memorial Hospital82016-01-012020-04-15
Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion
Clinolipid, Intralipid - Essential Fatty Acid Deficiency (EFAD)
Phase 4TerminatedBaxter Healthcare Corporation12015-05-012021-07-21
rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome
rtPA lock therapy - Short Bowel Syndrome
Phase 4CompletedLynn Malec82015-02-012018-02-06
Short Bowel Syndrome and Teduglutide Versus Placebo
Teduglutide, Placebo - Short Bowel Syndrome
Phase 4CompletedMayo Clinic82014-01-012016-02-22
Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
Exenatide, Placebo - Short Bowel Syndrome
Phase 4WithdrawnMayo Clinic2013-03-012014-01-14
The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients
ursodeoxycholic acid - Short Bowel Syndrome
Phase 4CompletedJinling Hospital, China302013-01-012017-02-24
rHGH and Intestinal Permeability in Intestinal Failure
Somatropin, Seven Day Food Diary, Blood Tests (standard of care) - Short Bowel Syndrome
Phase 4CompletedNorthwestern University152006-10-012016-02-08
Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
Growth Hormone - Short Bowel Syndrome
Phase 4TerminatedUniversity of Nebraska52003-09-012023-09-08

Narrower conditions

Hyperphagia (4)  ·  Pena Shokeir syndrome, type 1 (2)  ·  Intestinal Failure (1)  ·  Malabsorption Syndromes (1)

Broader conditions

Digestive System Diseases (13)  ·  Gastrointestinal Diseases (13)  ·  Intestinal Diseases (13)  ·  Pathologic Processes (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Postoperative Complications (13)  ·  Malabsorption Syndromes (12)  ·  Signs and Symptoms (4)  ·  Signs and Symptoms, Digestive (4)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Growth Hormone (2)  ·  Standard of Care (2)  ·  soybean oil, phospholipid emulsion (2)  ·  teduglutide (2)  ·  ALX-0600 (1)  ·  Angptl4 protein, mouse (1)  ·  Diet Records (1)  ·  Dipeptidyl-Peptidase IV Inhibitors (1)  ·  Exenatide (1)  ·  Hematologic Tests (1)  ·  Human Growth Hormone (1)  ·  SMOFlipid (1)  ·  Sitagliptin Phosphate (1)  ·  Urine Specimen Collection (1)  ·  Ursodeoxycholic Acid (1)

Sponsors

Mayo Clinic (3)  ·  Baxter Healthcare Corporation (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Changchun GeneScience Pharmaceutical Co., Ltd. (1)  ·  Jinling Hospital, China (1)  ·  Lynn Malec (1)  ·  Northwestern University (1)  ·  Stanley Dudrick's Memorial Hospital (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  University of Nebraska (1)

Countries

United States (7)  ·  China (2)  ·  Belgium (1)  ·  France (1)  ·  Poland (1)

Top investigators

Michael Camilleri, MD (2)  ·  Fedja Rochling, MB, ChB (1)  ·  Jonathan Fryer, MD (1)  ·  Lynn Malec, MD (1)  ·  Manpreet S Mundi (1)  ·  Wencheng Kong, MD (1)

Results publications

PMID 26223941, PMID 37270289, PMID 40415417

NIH funding

2017 (1), UL1TR000135 (1)